tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA

Zevra Therapeutics (ZVRA) Technical Analysis

711 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Zevra Therapeutics’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting Zevra Therapeutics is a Buy.
Zevra Therapeutics’s (ZVRA) 20-Day exponential moving average is 6.02, while Zevra Therapeutics’s (ZVRA) share price is $5.8, making it a Sell.
Zevra Therapeutics’s (ZVRA) 50-Day exponential moving average is 6.02, while Zevra Therapeutics’s (ZVRA) share price is $5.8, making it a Sell.

Zevra Therapeutics (ZVRA) Pivot Points

Apr 27, 2024, 09:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.57
5.65
5.80
5.88
6.03
6.11
6.26
Fibonacci
5.65
5.74
5.80
5.88
5.97
6.03
6.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Apr 27, 2024, 09:44 AM
Period
Simple
Exponential
MA5
5.77Buy
5.82Sell
MA10
5.87Sell
5.89Sell
MA20
6.07Sell
6.02Sell
MA50
6.15Sell
6.02Sell
MA100
5.62Buy
5.77Buy
MA200
5.28Buy
5.50Buy
Zevra Therapeutics’s (ZVRA) 10-Day exponential moving average is 5.89, while Zevra Therapeutics’s (ZVRA) share price is $5.8, making it a Sell.
Zevra Therapeutics’s (ZVRA) 100-Day exponential moving average is 5.77, while Zevra Therapeutics’s (ZVRA) share price is $5.8, making it a Buy.
Zevra Therapeutics’s (ZVRA) stock price is $5.8 and Zevra Therapeutics’s (ZVRA) 50-day simple moving average is 6.15, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) stock price is $5.8 and Zevra Therapeutics’s (ZVRA) 100-day simple moving average is 5.62, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) stock price is $5.8 and Zevra Therapeutics’s (ZVRA) 200-day simple moving average is 5.28, creating a Buy signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Apr 27, 2024, 09:44 AM
Name
Value
Implied Action
RSI (14)
43.27
Neutral
STOCH (9,6)
30.40
Neutral
STOCHRSI (14)
25.84
Neutral
MACD (12,26)
-0.14
Buy
ADX (14)
18.50
Buy
Williams %R
-76.40
Buy
CCI (14)
-43.42
Neutral
ATR (14)
0.32
-
Ultimate Oscillator
32.14
Neutral
ROC
-4.92
Sell
Zevra Therapeutics’s (ZVRA) Relative Strength Index (RSI) is 43.27, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Trend Strength Indicator (ADX) is 18.50, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) Commodity Channel Index (CCI) is -43.42, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Price Rate of Change (ROC) is -4.92, creating a Sell signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Hold.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 43.27, which suggests ZVRA is a Neutral.
      What is ZVRA’s MACD?
      ZVRA’s MACD is -0.14, which suggests ZVRA is a Buy.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 5.77, which suggests ZVRA is a Buy.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 6.07, which suggests ZVRA is a Sell.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 6.15, which suggests ZVRA is a Sell.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 5.28, which suggests ZVRA is a Buy.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -76.40, which suggests ZVRA is a Buy.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is -43.42, which suggests ZVRA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis